Trimetazidine Dihydrochloride
Generic / Active Ingredient
What is Trimetazidine Dihydrochloride used for?
Meniere’s disease
26 Trimetazidine Dihydrochloride brands in Bangladesh
Compare prices across every brand of Trimetazidine Dihydrochloride and pick the most affordable option.
| Brand | Strength | Form | Manufacturer | Price |
|---|---|---|---|---|
| Angimet | 20 mg | Tablet | Orion Pharma Ltd. | ৳ 3.01 |
| Angimet MR | 35 mg | Tablet (Modified Release) | Orion Pharma Ltd. | ৳ 6.00 |
| Anginox MR | 35 mg | Tablet (Modified Release) | General Pharmaceuticals Ltd. | ৳ 6.00 |
| Angirid MR | 35 mg | Tablet (Modified Release) | ACME Laboratories Ltd. | ৳ 5.80 |
| Angitrim MR | 35 mg | Tablet (Modified Release) | Globe Pharmaceuticals Ltd. | ৳ 6.00 |
| Angivas MR | 35 mg | Tablet (Modified Release) | Popular Pharmaceuticals Ltd. | ৳ 5.00 |
| Angivent MR | 35 mg | Tablet (Modified Release) | Square Pharmaceuticals Ltd. | ৳ 8.00 |
| Antoris MR | 35 mg | Tablet (Modified Release) | Opsonin Pharma Ltd. | ৳ 6.02 |
| Cardimet MR | 35 mg | Tablet (Modified Release) | Eskayef Pharmaceuticals Ltd. | ৳ 6.00 |
| Feelnor MR | 35 mg | Tablet (Modified Release) | Incepta Pharmaceuticals Ltd. | ৳ 6.75 |
| Metacard MR | 35 mg | Tablet (Modified Release) | Aristopharma Ltd. | ৳ 8.00 |
| Metavas MR | 35 mg | Tablet (Modified Release) | NIPRO JMI Pharma Ltd. | ৳ 6.90 |
| Metazine MR | 35 mg | Tablet (Modified Release) | Beximco Pharmaceuticals Ltd. | ৳ 6.00 |
| Trangina MR | 35 mg | Tablet (Modified Release) | Biopharma Laboratories Ltd. | ৳ 6.00 |
| Trangit MR | 35 mg | Tablet (Modified Release) | SANDOZ (A Novartis Division) | ৳ 8.27 |
| Triginal MR | 35 mg | Tablet (Modified Release) | Radiant Pharmaceuticals Ltd. | ৳ 8.00 |
| Trimacontin | 60 mg | Tablet (Modified Release) | Mundipharma (BD) Pvt. Ltd. | ৳ 15.00 |
| Trimacontin | 35 mg | Tablet (Modified Release) | Mundipharma (BD) Pvt. Ltd. | ৳ 9.00 |
| Trimet | 20 mg | Tablet | Drug International Ltd. | ৳ 3.00 |
| Trimet-MR | 35 mg | Tablet (Modified Release) | Drug International Ltd. | ৳ 6.00 |
| Trizedon MR | 35 mg | Tablet (Modified Release) | Renata Limited | ৳ 8.00 |
| Vascare | 20 mg | Tablet | Doctor TIMS Pharmaceuticals Ltd. | ৳ 3.00 |
| Vaspec MR | 35 mg | Tablet (Modified Release) | Navana Pharmaceuticals Ltd. | ৳ 6.00 |
| Vastadin MR | 35 mg | Tablet (Modified Release) | Sharif Pharmaceuticals Ltd. | ৳ 5.01 |
| Vastarel MR | 35 mg | Tablet (Modified Release) | Servier Bangladesh Operation | ৳ 9.03 |
| Vestar MR | 35 mg | Tablet (Modified Release) | Healthcare Pharmaceuticals Ltd. | ৳ 8.00 |
Indication DetailsView
Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.
Therapeutic ClassView
Other Anti-anginal & Anti-ischaemic drugs
PharmacologyView
Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.
DosageView
The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.
Side EffectsView
Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia
ContraindicationsView
Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.
PrecautionsView
Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.
InteractionsView
No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.
Pregnancy & LactationView
There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.
Storage ConditionsView
Keep in a dry place away from light and heat. Keep out of the reach of children.